Targeting mycobacterium protein tyrosine phosphatase B for antituberculosis agents

Protein tyrosine phosphatases are often exploited and subverted by pathogenic bacteria to cause human diseases. The tyrosine phosphatase mPTPB from Mycobacterium tuberculosis is an essential virulence factor that is secreted by the bacterium into the cytoplasm of macrophages, where it mediates mycobacterial survival in the host. Consequently, there is considerable interest in understanding the mechanism by which mPTPB evades the host immune responses, and in developing potent and selective mPTPB inhibitors as unique antituberculosis (antiTB) agents. We uncovered that mPTPB subverts the innate immune responses by blocking the ERK1/2 and p38 mediated IL-6 production and promoting host cell survival by activating the Akt pathway. We identified a potent and selective mPTPB inhibitor I-A09 with highly efficacious cellular activity, from a combinatorial library of bidentate benzofuran salicylic acid derivatives assembled by click chemistry. We demonstrated that inhibition of mPTPB with I-A09 in macrophages reverses the altered host immune responses induced by the bacterial phosphatase and prevents TB growth in host cells. The results provide the necessary proof-of-principle data to support the notion that specific inhibitors of the mPTPB may serve as effective antiTB therapeutics.

[1]  A. Ullrich,et al.  Interplay between mycobacteria and host signalling pathways , 2004, Nature Reviews Microbiology.

[2]  T. Alber,et al.  Fragment-based substrate activity screening method for the identification of potent inhibitors of the Mycobacterium tuberculosis phosphatase PtpB. , 2007, Journal of the American Chemical Society.

[3]  C. Seto,et al.  A two stage click-based library of protein tyrosine phosphatase inhibitors. , 2007, Bioorganic & medicinal chemistry.

[4]  T. van der Poll,et al.  Interleukin-6 gene-deficient mice show impaired defense against pneumococcal pneumonia. , 1997, The Journal of infectious diseases.

[5]  Gang Liu,et al.  Inhibition of MptpB phosphatase from Mycobacterium tuberculosis impairs mycobacterial survival in macrophages. , 2009, The Journal of antimicrobial chemotherapy.

[6]  Zoran Radić,et al.  In situ click chemistry: enzyme inhibitors made to their own specifications. , 2004, Journal of the American Chemical Society.

[7]  J. Bliska,et al.  Identification of p130Cas as a substrate of Yersinia YopH (Yop51), a bacterial protein tyrosine phosphatase that translocates into mammalian cells and targets focal adhesions , 1997, The EMBO journal.

[8]  P. Taylor,et al.  Click chemistry in situ: acetylcholinesterase as a reaction vessel for the selective assembly of a femtomolar inhibitor from an array of building blocks. , 2002, Angewandte Chemie.

[9]  Mahesh Uttamchandani,et al.  Rapid assembly and in situ screening of bidentate inhibitors of protein tyrosine phosphatases. , 2006, Organic letters.

[10]  A. Alonso,et al.  Aurintricarboxylic Acid Blocks in Vitro and in Vivo Activity of YopH, an Essential Virulent Factor of Yersinia pestis, the Agent of Plague* , 2003, Journal of Biological Chemistry.

[11]  M. Finn,et al.  Click Chemistry: Diverse Chemical Function from a Few Good Reactions. , 2001 .

[12]  Joanna M. Sasin,et al.  Protein Tyrosine Phosphatases in the Human Genome , 2004, Cell.

[13]  M. Hukkanen,et al.  Interferon-γ induces C/EBPβ expression and activity through MEK/ERK and p38 in T84 colon epithelial cells , 2003 .

[14]  Chi-Huey Wong,et al.  A potent and highly selective inhibitor of human alpha-1,3-fucosyltransferase via click chemistry. , 2003, Journal of the American Chemical Society.

[15]  K. Schroder,et al.  Interferon- : an overview of signals, mechanisms and functions , 2004 .

[16]  S. Roy,et al.  ERK1 and ERK2 Activate CCAAAT/Enhancer-binding Protein-β-dependent Gene Transcription in Response to Interferon-γ* , 2001, The Journal of Biological Chemistry.

[17]  Chi‐Huey Wong,et al.  A Potent and Highly Selective Inhibitor of Human α-1,3-Fucosyltransferase via Click Chemistry , 2003 .

[18]  A. Clatworthy,et al.  Targeting virulence: a new paradigm for antimicrobial therapy , 2007, Nature Chemical Biology.

[19]  G. Lushington,et al.  Parallel synthesis of a multi-substituted benzo[b]furan library. , 2008, Journal of combinatorial chemistry.

[20]  K. Schroder,et al.  Interferon-gamma: an overview of signals, mechanisms and functions. , 2004, Journal of leukocyte biology.

[21]  Peter J Hume,et al.  The Salmonella Effector SptP Dephosphorylates Host AAA+ ATPase VCP to Promote Development of its Intracellular Replicative Niche , 2009, Cell host & microbe.

[22]  M. G. Finn,et al.  Click Chemistry: Diverse Chemical Function from a Few Good Reactions. , 2001, Angewandte Chemie.

[23]  S. Franzblau,et al.  In Vitro and In Vivo Activities of Macrolide Derivatives against Mycobacterium tuberculosis , 2005, Antimicrobial Agents and Chemotherapy.

[24]  Ramandeep Singh,et al.  Disruption of mptpB impairs the ability of Mycobacterium tuberculosis to survive in guinea pigs , 2003, Molecular microbiology.

[25]  Jacques Neefjes,et al.  Intracellular bacterial growth is controlled by a kinase network around PKB/AKT1 , 2007, Nature.

[26]  Y. Keng,et al.  Structure-based discovery of small molecule inhibitors targeted to protein tyrosine phosphatase 1B. , 2000, Journal of medicinal chemistry.

[27]  B. Neel,et al.  Combinatorial control of the specificity of protein tyrosine phosphatases. , 2001, Current opinion in cell biology.

[28]  Zhon-Yin Zhang,et al.  Protein tyrosine phosphatases: structure and function, substrate specificity, and inhibitor development. , 2002, Annual review of pharmacology and toxicology.

[29]  Z. Zhang,et al.  Protein tyrosine phosphatases: prospects for therapeutics. , 2001, Current opinion in chemical biology.

[30]  R. Schreiber,et al.  ERK1 and ERK2 activate CCAAAT/enhancer-binding protein-beta-dependent gene transcription in response to interferon-gamma. , 2001, The Journal of biological chemistry.

[31]  K. Saxena,et al.  Brunsvicamides A-C: sponge-related cyanobacterial peptides with Mycobacterium tuberculosis protein tyrosine phosphatase inhibitory activity. , 2006, Journal of medicinal chemistry.

[32]  Herbert Waldmann,et al.  Discovery of protein phosphatase inhibitor classes by biology-oriented synthesis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[33]  Ying Zhang,et al.  The magic bullets and tuberculosis drug targets. , 2005, Annual review of pharmacology and toxicology.

[34]  Declan Butler,et al.  New fronts in an old war , 2000, Nature.

[35]  B. Barrell,et al.  Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence , 1998, Nature.

[36]  C. Gee,et al.  Structural basis for selective inhibition of Mycobacterium tuberculosis protein tyrosine phosphatase PtpB. , 2007, Structure.